Loading Events

« All Events

  • This event has passed.

FDA/CDER and AASLD 2021 DILI Conference XVIII

April 20, 2021 @ 9:00 am - April 22, 2021 @ 4:00 pm

Virtual Conference: Hepatotoxicity related to pharmaceutical drugs, biological agents, and dietary supplements from a clinical, non-clinical, and post-marketing perspective.

Poster Presentations:

Session Presentations:

Wednesday, April 21, 2021 –

  • Paul Watkins (and William Proctor) will be the moderate Session III: Innovative Tools to Predict and Diagnose DILI. During this session James Beaudoin will present, Quantitative Systems Modeling: Can it Predict Disease-Related DILI Risk? from 9:10 – 9:30 AM EDT.
  • Paul Watkins will present during Session IV: Cancer Drugs & Hepatotoxicity, CTCAE Grading and Other Approaches to Measure DILI Severity: What Makes Sense? from 11:30-11:50 AM EDT.

Conference details:

https://www.fda.gov/drugs/news-events-human-drugs/fdacder-and-aasld-2021-dili-conference-xviii-04202021-04222021

https://www.aasld.org/event/aasld-fda-dili-conference

Details

Start:
April 20, 2021 @ 9:00 am
End:
April 22, 2021 @ 4:00 pm
Website:
https://www.fda.gov/drugs/news-events-human-drugs/fdacder-and-aasld-2021-dili-conference-xviii-04202021-04222021

In Case You Missed A Recent Webinar or Product Video:

What’s new in MonolixSuite 2021

ADMET Predictor® 10.3 (APX.3): Flagship machine learning platform for ADMET modeling